Eyes on the prize: federal Alzheimer's research effort aims to facilitate interventions.
The public Alzheimer's disease (AD) research enterprise began in earnest in the mid-1970s with the creation by Congress of the National Institute on Aging at the National Institutes of Health. Today, AD research is a maturing field of study, with federal effort seeking to encourage the creativity and insights of individual investigators, and targeting special areas for emphasis. It is inspired by the legacy of our friend and colleague Leon Thal, whose innovative and collaborative approach to scientific research serves as a guidepost as we move toward the discovery of new and effective ways to prevent AD or slow its progression. This article describes the progress to date and potentially promising areas of study from the vantage point of the National Institute on Aging.
Hodes
Richard J
RJ
National Institute on Aging, National Institutes of Health, U.S. Department of Health and Human Services, Bethesda, MD, USA.
Buckholtz
Neil
N
Cahan
Vicky
V
Morrison-Bogorad
Marcelle
M
D000047:Academies and Institutes; D000544:Alzheimer Disease / Q000266:history / Q000628:therapy; D000818:Animals; D002986:Clinical Trials as Topic; D035082:Federal Government; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D014481:United States